Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Moderna
MRNA
|
$903M |
| 2 |
Charles Schwab
SCHW
|
$631M |
| 3 |
Affirm
AFRM
|
$556M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
$514M |
| 5 |
Coupang
CPNG
|
$458M |
Top Sells
| 1 |
Tesla
TSLA
|
$3.23B |
| 2 |
Full Truck Alliance
YMM
|
$995M |
| 3 |
ResMed
RMD
|
$718M |
| 4 |
NVIDIA
NVDA
|
$691M |
| 5 |
Amazon
AMZN
|
$509M |
Sector Composition
| 1 | Consumer Discretionary | 26.58% |
| 2 | Healthcare | 23.23% |
| 3 | Technology | 21.05% |
| 4 | Communication Services | 12.81% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Medtronic
MDT
$118B
| $35.9M | 0.02% |
347,088
+33,608
| +11% | +$3.48M |
|
202
Cullen/Frost Bankers
CFR
$8.28B
| $34.4M | 0.02% |
272,884
+27,162
| +11% | +$3.42M |
|
203
Digimarc
DMRC
$171M
| $33.9M | 0.02% |
859,791
+33,207
| +4% | +$1.31M |
|
204
Dolby
DLB
$6.94B
| $33.9M | 0.02% |
355,676
+43,572
| +14% | +$4.15M |
|
205
Clear Secure
YOU
$3.45B
| $31.4M | 0.02% |
1,000,000
| – | – |
|
206
Clover Health Investments
CLOV
$1.36B
| $29M | 0.02% |
7,787,680
+2,645,503
| +51% | +$9.84M |
|
207
dLocal
DLO
$4.09B
| $28.6M | 0.02% |
800,142
+142
| +0% | +$5.07K |
|
208
Sutro Biopharma
STRO
$85.6M
| $27.6M | 0.02% |
1,855,250
+60,310
| +3% | +$897K |
|
209
Waters Corp
WAT
$17.3B
| $27.4M | 0.02% |
73,445
+3,312
| +5% | +$1.23M |
|
|
AMBR
210
Amber International Holding Limited American Depositary Shares
AMBR
$359M
| $27.3M | 0.02% |
591,775
+59,086
| +11% | +$2.72M |
|
211
Quanterix
QTRX
$202M
| $26.6M | 0.01% |
626,602
+25,044
| +4% | +$1.06M |
|
212
Masimo
MASI
$7.43B
| $26.3M | 0.01% |
89,929
+3,561
| +4% | +$1.04M |
|
213
NetEase
NTES
$85.4B
| $26.3M | 0.01% |
258,292
+6,264
| +2% | +$638K |
|
214
StoneCo
STNE
$4.38B
| $25.3M | 0.01% |
1,502,088
-1,713
| -0.1% | -$28.9K |
|
|
215
ResMed
RMD
$39.4B
| $24.7M | 0.01% |
94,670
-2,755,472
| -97% | -$718M |
|
|
MEKA
216
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $23.1M | 0.01% |
2,000,000
| – | – |
|
217
Zillow
ZG
$19.6B
| $22.6M | 0.01% |
363,269
-3,273,746
| -90% | -$204M |
|
218
Stratasys
SSYS
$863M
| $22.3M | 0.01% |
909,769
+35,386
| +4% | +$867K |
|
219
EverQuote
EVER
$841M
| $21.9M | 0.01% |
1,399,098
+59,477
| +4% | +$931K |
|
220
CEVA Inc
CEVA
$520M
| $21.4M | 0.01% |
496,018
+16,554
| +3% | +$716K |
|
|
BZUN
221
Baozun
BZUN
$233M
| $21.2M | 0.01% |
1,524,932
+23,592
| +2% | +$328K |
|
222
QuantumScape
QS
$4.4B
| $20.3M | 0.01% |
916,193
+84
| +0% | +$1.86K |
|
|
ZY
223
DELISTED
Zymergen Inc. Common Stock
ZY
| $18.9M | 0.01% |
2,821,956
| – | – |
|
|
YSG
224
Yatsen Holding
YSG
$873M
| $17.8M | 0.01% |
1,651,931
-782,947
| -32% | -$8.42M |
|
225
Burford Capital
BUR
$2.89B
| $16.9M | 0.01% |
1,618,324
+580,215
| +56% | +$6.06M |
|